![](/img/cover-not-exists.png)
Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
Dietel, M., Savelov, N., Salanova, R., Micke, P., Bigras, G., Hida, T., Antunez, J., Guldhammer Skov, B., Hutarew, G., Sua, L.F., Akita, H., Chan, O.S.H., Piperdi, B., Burke, T., Khambata-Ford, S., DeVolume:
134
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2019.06.012
Date:
August, 2019
File:
PDF, 2.11 MB
2019